Literature DB >> 20640944

Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

José A García-Donaire1, Luis M Ruilope.   

Abstract

Chronic kidney disease is a leading global health problem with an increasing prevalence. Hypertension is present in most patients with chronic kidney disease, and hypertension-related nephrosclerosis is a top cause of progressive renal damage and end-stage renal disease. Systolic blood pressure (BP) and pulse pressure, together with nocturnal BP, are the most important factors favoring the progression of renal failure. Consequently, strict control of BP and other cardiovascular risk factors is required, including an adequate degree of suppression of the renin-angiotensin system in every patient.

Entities:  

Mesh:

Year:  2010        PMID: 20640944     DOI: 10.1007/s11906-010-0129-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  64 in total

1.  The paradigm has shifted, to systolic blood pressure.

Authors:  H R Black
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

Review 2.  The case for using albuminuria in staging chronic kidney disease.

Authors:  Ron T Gansevoort; Paul E de Jong
Journal:  J Am Soc Nephrol       Date:  2009-03       Impact factor: 10.121

3.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population.

Authors:  A Benetos; M Safar; A Rudnichi; H Smulyan; J L Richard; P Ducimetieère; L Guize
Journal:  Hypertension       Date:  1997-12       Impact factor: 10.190

4.  Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Authors:  Scott D Solomon; Madeline M Rice; Kathleen A Jablonski; Powell Jose; Michael Domanski; Marc Sabatine; Bernard J Gersh; Jean Rouleau; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

Review 5.  Epidemiology of coronary heart disease.

Authors:  J Stamler
Journal:  Med Clin North Am       Date:  1973-01       Impact factor: 5.456

Review 6.  Systolic blood pressure: it's time to take control.

Authors:  Stanley S Franklin
Journal:  Am J Hypertens       Date:  2004-12       Impact factor: 2.689

7.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

8.  Acetaminophen, aspirin and progression of advanced chronic kidney disease.

Authors:  Marie Evans; Carl Michael Fored; Rino Bellocco; Garrett Fitzmaurice; Jon P Fryzek; Joseph K McLaughlin; Olof Nyrén; Carl-Gustaf Elinder
Journal:  Nephrol Dial Transplant       Date:  2009-01-20       Impact factor: 5.992

9.  Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study.

Authors:  Miranda T Schram; Pieter J Kostense; Robert A Van Dijk; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Robert J Heine; Coen D Stehouwer
Journal:  J Hypertens       Date:  2002-09       Impact factor: 4.844

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  2 in total

1.  Clinical Significance of Pre-Transplant Arterial Stiffness and the Impact of Kidney Transplantation on Arterial Stiffness.

Authors:  Hyun Seon Kim; Jaeho Seung; Ju Hyun Lee; Byung Ha Chung; Chul Woo Yang
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

2.  Association between temperature and emergency room visits for cardiorespiratory diseases, metabolic syndrome-related diseases, and accidents in metropolitan Taipei.

Authors:  Yu-Chun Wang; Yu-Kai Lin
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.